Calendar

pharmadog

Week of Dec 15, 2025

Dec 16, 2025approval256d agoVYBRIQUE (SILDENAFIL CITRATE) — FDA approvalRevatio

Sponsor: IBSA. Form: FILM. Route: ORAL

full page →Revatio →fda approvals ↗

Dec 16, 2025approval256d agoLOSARTAN POTASSIUM — FDA approvalLOSARTAN POTASSIUM

Sponsor: HETERO LABS LTD V. Form: TABLET. Route: ORAL

full page →LOSARTAN POTASSIUM →fda approvals ↗

Dec 16, 2025approval256d agoBECLOMETHASONE DIPROPIONATE — FDA approvalSOLIGENIX, INC.

Sponsor: AMNEAL IRELAND LTD. Form: AEROSOL, METERED. Route: INHALATION

full page →fda approvals ↗

Dec 16, 2025approval256d agoLOSARTAN POTASSIUM — FDA approvalAlembic Pharmaceuticals Inc

Sponsor: ALEMBIC PHARMS LTD. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Dec 17, 2025approval255d agoWAINUA (AUTOINJECTOR) (EPLONTERSEN SODIUM) — FDA approvaleplontersen sodium

Sponsor: ASTRAZENECA AB. Form: SOLUTION. Route: SUBCUTANEOUS

full page →eplontersen sodium →fda approvals ↗

Dec 17, 2025approval255d agoZYNYZ (RETIFANLIMAB-DLWR) — FDA approvalretifanlimab

Sponsor: INCYTE CORP. Form: INJECTABLE. Route: INTRAVENOUS

full page →retifanlimab →fda approvals ↗

Dec 17, 2025approval255d agoXeomin (incobotulinumtoxinA) — FDA approvalMerz Pharmaceuticals LLC

Sponsor: MERZ PHARMS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Dec 17, 2025approval255d agoGABAPENTIN — FDA approvalGABAPENTIN

Sponsor: SANDOZ. Form: CAPSULE. Route: ORAL

full page →GABAPENTIN →fda approvals ↗

Dec 17, 2025approval255d agoGAZYVA (OBINUTUZUMAB) — FDA approvalobinutuzumab

Sponsor: GENENTECH. Form: INJECTABLE. Route: INJECTION

full page →obinutuzumab →fda approvals ↗

Dec 17, 2025approval255d agoBORTEZOMIB — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: SHUANGCHENG. Form: INJECTABLE. Route: INTRAVENOUS, SUBCUTANEOUS

full page →fda approvals ↗

Dec 17, 2025approval255d agoLATANOPROST — FDA approvalXalatan

Sponsor: MANKIND PHARMA. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →Xalatan →fda approvals ↗

Dec 17, 2025approval255d agoVINCRISTINE SULFATE PFS (VINCRISTINE SULFATE) — FDA approvalVINCRISTINE SULFATE PFS

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →VINCRISTINE SULFATE PFS →fda approvals ↗

Dec 17, 2025approval255d agoACETAMINOPHEN AND IBUPROFEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

Sponsor: GRANULES. Form: TABLET. Route: ORAL

full page →acetaminophen ER →fda approvals ↗

Dec 17, 2025approval255d agoORILISSA (ELAGOLIX SODIUM) — FDA approvalelagolix sodium

Sponsor: ABBVIE. Form: TABLET. Route: ORAL

full page →elagolix sodium →fda approvals ↗

Dec 17, 2025approval255d agoRYBREVANT FASPRO (AMIVANTAMAB AND HYALURONIDASE-LPUJ) — FDA approval(amivantamab + hyaluronidase (human recombinant))

Sponsor: JANSSEN BIOTECH. Form: INJECTION

full page →(amivantamab + hyaluronidase (human recombinant)) →fda approvals ↗

Dec 17, 2025approval255d agoRUBRACA (RUCAPARIB CAMSYLATE) — FDA approvalrucaparib camsylate

Sponsor: PHARMAAND. Form: TABLET. Route: ORAL

full page →rucaparib camsylate →fda approvals ↗

Dec 17, 2025approval255d agoRUBRACA (RUCAPARIB CAMSYLATE) — FDA approvalrucaparib camsylate

Sponsor: PHARMAAND. Form: TABLET. Route: ORAL

full page →rucaparib camsylate →fda approvals ↗

Dec 17, 2025approval255d agoCIPROFLOXACIN HYDROCHLORIDE — FDA approvalBayer HealthCare Pharmaceuticals Inc

Sponsor: UNIQUE. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Dec 17, 2025approval255d agoTESTOSTERONE — FDA approvalTransdermal Delivery Solutions Corp

Sponsor: ENCUBE. Form: GEL. Route: TRANSDERMAL

full page →fda approvals ↗

Dec 17, 2025approval255d agoORIAHNN (COPACKAGED) (ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE) — FDA approvalORIAHNN (COPACKAGED)

Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL

full page →ORIAHNN (COPACKAGED) →fda approvals ↗

Dec 17, 2025approval255d agoABRILADA (ADALIMUMAB-AFZB) — FDA approvalABRILADA

Sponsor: PFIZER INC. Form: INJECTABLE. Route: INJECTION

full page →ABRILADA →fda approvals ↗

Dec 17, 2025approval255d agoTRAVOPROST — FDA approvalTRAVOPROST

Sponsor: ALEMBIC. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →TRAVOPROST →fda approvals ↗

Dec 17, 2025approval255d agoADBRY (TRALOKINUMAB) — FDA approvaltralokinumab

Sponsor: LEO PHARMA AS. Form: INJECTABLE. Route: INJECTION

full page →tralokinumab →fda approvals ↗

Dec 18, 2025approval254d agoCLOMIPHENE CITRATE — FDA approvalCLOMIPHENE CITRATE

Sponsor: COSETTE. Form: TABLET. Route: ORAL

full page →CLOMIPHENE CITRATE →fda approvals ↗

Dec 18, 2025approval254d agoVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalCARIPRAZINE HYDROCHLORIDE

Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL

full page →CARIPRAZINE HYDROCHLORIDE →fda approvals ↗

Dec 18, 2025approval254d agoVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalCARIPRAZINE HYDROCHLORIDE

Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL

full page →CARIPRAZINE HYDROCHLORIDE →fda approvals ↗

Dec 18, 2025approval254d agoVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalCARIPRAZINE HYDROCHLORIDE

Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL

full page →CARIPRAZINE HYDROCHLORIDE →fda approvals ↗

Dec 18, 2025approval254d agoVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalCARIPRAZINE HYDROCHLORIDE

Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL

full page →CARIPRAZINE HYDROCHLORIDE →fda approvals ↗

Dec 18, 2025approval254d agoNITROGLYCERIN — FDA approvalNITROGLYCERIN

Sponsor: SOLARIS PHARMA CORP. Form: OINTMENT. Route: INTRA-ANAL

full page →NITROGLYCERIN →fda approvals ↗

Dec 18, 2025approval254d agoBUPRENORPHINE HYDROCHLORIDE — FDA approvalBUPRENORPHINE HYDROCHLORIDE

Sponsor: ASCENT PHARMS INC. Form: TABLET. Route: SUBLINGUAL

full page →BUPRENORPHINE HYDROCHLORIDE →fda approvals ↗

Dec 18, 2025approval254d agoNICARDIPINE HYDROCHLORIDE — FDA approvalNICARDIPINE HYDROCHLORIDE

Sponsor: CHENGDU SHUODE. Form: INJECTABLE. Route: INJECTION

full page →NICARDIPINE HYDROCHLORIDE →fda approvals ↗

Dec 18, 2025approval254d agoNUFYMCO (RANIBIZUMAB-LEYK) — FDA approvalNUFYMCO

Sponsor: FORMYCON AG. Form: INJECTION

full page →NUFYMCO →fda approvals ↗

Dec 18, 2025approval254d agoVARENICLINE TARTRATE — FDA approvalVARENICLINE TARTRATE

Sponsor: LUPIN LTD. Form: TABLET. Route: ORAL

full page →VARENICLINE TARTRATE →fda approvals ↗

Dec 18, 2025approval254d agoTENOFOVIR DISOPROXIL FUMARATE — FDA approvalTENOFOVIR DISOPROXIL FUMARATE

Sponsor: MICRO LABS. Form: TABLET. Route: ORAL

full page →TENOFOVIR DISOPROXIL FUMARATE →fda approvals ↗

Dec 18, 2025approval254d agoHALOPERIDOL — FDA approvalCreekwood Pharmaceutical Inc

Sponsor: CREEKWOOD PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Dec 19, 2025approval253d agoMYQORZO (AFICAMTEN) — FDA approvalaficamten

Sponsor: CYTOKINETICS. Form: TABLET. Route: ORAL

full page →aficamten →fda approvals ↗

Dec 19, 2025approval253d agoMOUNJARO (TIRZEPATIDE) — FDA approvalZEPBOUND

Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS

full page →ZEPBOUND →fda approvals ↗

Dec 19, 2025approval253d agoDECITABINE — FDA approvalDECITABINE

Sponsor: RELIANCE LIFE SCI. Form: INJECTABLE. Route: INTRAVENOUS

full page →DECITABINE →fda approvals ↗

Dec 19, 2025approval253d agoLUNSUMIO (MOSUNETUZUMAB-AXGB) — FDA approvalmosunetuzumab

Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INJECTION

full page →mosunetuzumab →fda approvals ↗

Dec 19, 2025approval253d agoREZDIFFRA (RESMETIROM) — FDA approvalresmetirom

Sponsor: MADRIGAL. Form: TABLET. Route: ORAL

full page →resmetirom →fda approvals ↗

Dec 19, 2025approval253d agoREZDIFFRA (RESMETIROM) — FDA approvalresmetirom

Sponsor: MADRIGAL. Form: TABLET. Route: ORAL

full page →resmetirom →fda approvals ↗

Dec 19, 2025approval253d agoREZDIFFRA (RESMETIROM) — FDA approvalresmetirom

Sponsor: MADRIGAL. Form: TABLET. Route: ORAL

full page →resmetirom →fda approvals ↗

Dec 19, 2025approval253d agoJASCAYD (NERANDOMILAST) — FDA approvalnerandomilast

Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL

full page →nerandomilast →fda approvals ↗

Dec 19, 2025approval253d agoBONCRESA (DENOSUMAB-MOBZ) — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: AMNEAL PHARMS LLC. Form: INJECTABLE. Route: SUBCUTANEOUS

full page →fda approvals ↗

Dec 19, 2025approval253d agoOZILTUS (DENOSUMAB-MOBZ) — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: AMNEAL PHARMS LLC. Form: INJECTABLE. Route: SUBCUTANEOUS

full page →fda approvals ↗

Dec 19, 2025approval253d agoFLONASE SENSIMIST ALLERGY RELIEF (FLUTICASONE FUROATE) — FDA approvalGlaxoSmithKline LLC

Sponsor: HALEON US HOLDINGS. Form: SPRAY, METERED. Route: NASAL

full page →fda approvals ↗

Dec 19, 2025approval253d agoBYLVAY (ODEVIXIBAT) — FDA approvalodevixibat

Sponsor: IPSEN. Form: CAPSULE. Route: ORAL

full page →odevixibat →fda approvals ↗

Dec 19, 2025approval253d agoACCRUFER (FERRIC MALTOL) — FDA approvalferric maltol

Sponsor: SHIELD TX. Form: CAPSULE. Route: ORAL

full page →ferric maltol →fda approvals ↗

Dec 19, 2025approval253d agoFLONASE ALLERGY RELIEF (FLUTICASONE PROPIONATE) — FDA approvalParatek Pharmaceuticals Inc

Sponsor: HALEON US HOLDINGS. Form: SPRAY, METERED. Route: NASAL

full page →fda approvals ↗

Dec 19, 2025approval253d agoZINGO (LIDOCAINE HYDROCHLORIDE) — FDA approvalPowder Pharmaceuticals Inc

Sponsor: POWDER PHARMS. Form: SYSTEM. Route: INTRADERMAL

full page →fda approvals ↗

← prev

page 348 of 380

Week of Dec 15, 2025